NEW YORK – The American Food and Drug Administration (FDA) would be ready to authorize a ‘mix-and-match’ approach in the US for the recall of the anti-Covid vaccine, allowing for the third dose the use of a shield product other than that administered in the primary vaccination course, according to reports from the New York Times. The US authorities will not recommend any specific vaccines but will leave doctors the flexibility to choose a different brand, specifies the American newspaper. At best, the FDA could say that it is preferable to receive the same product for the recall but without this being binding.
USA, experts undecided on the need for the third dose for those vaccinated with Moderna and Johnson & Johnson
by Elena Dusi
Last month, the FDA gave the green light for Pfizer-BioNTech vaccine boosters to be done at least 6 months after the second dose. The agency should now also comment on the recalls of Moderna and Johnson & Johnson, and could do so by tomorrow, according to the US newspaper. The possible choice of the FDA not to bind the use of the same product for the booster would also be in line with a US study published just last week that tested boosters other than the vaccine used initially, with Moderna, Pfizer and J&J, with positive results. .
Vaccines, four Nordic countries suspend Moderna for males under 30
by Elena Dusi
.